These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

936 related items for PubMed ID: 24064322

  • 1. Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
    Nakajima N, Kataoka M, Sugawara Y, Ochi T, Kiyoto S, Ohsumi S, Mochizuki T.
    Int J Radiat Oncol Biol Phys; 2013 Nov 15; 87(4):738-46. PubMed ID: 24064322
    [Abstract] [Full Text] [Related]

  • 2. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.
    Shim SH, Kim DY, Lee DY, Lee SW, Park JY, Lee JJ, Kim JH, Kim YM, Kim YT, Nam JH.
    BJOG; 2014 Aug 15; 121(9):1097-106; discussion 1106. PubMed ID: 24397772
    [Abstract] [Full Text] [Related]

  • 3. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
    Abd El-Hafez YG, Moustafa HM, Khalil HF, Liao CT, Yen TC.
    Oral Oncol; 2013 Mar 15; 49(3):261-8. PubMed ID: 23036774
    [Abstract] [Full Text] [Related]

  • 4. New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer.
    Melloni G, Gajate AM, Sestini S, Gallivanone F, Bandiera A, Landoni C, Muriana P, Gianolli L, Zannini P.
    Eur J Surg Oncol; 2013 Nov 15; 39(11):1254-61. PubMed ID: 23948705
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The correlation of 18F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer.
    Qu YH, Long N, Ran C, Sun J.
    Clin Transl Oncol; 2021 Mar 15; 23(3):620-627. PubMed ID: 32683540
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
    Song BI, Lee SW, Jeong SY, Chae YS, Lee WK, Ahn BC, Lee J.
    J Nucl Med; 2012 Sep 15; 53(9):1337-44. PubMed ID: 22870824
    [Abstract] [Full Text] [Related]

  • 11. FDG Avidity and Tumor Burden: Survival Outcomes for Patients With Recurrent Breast Cancer.
    Taghipour M, Wray R, Sheikhbahaei S, Wright JL, Subramaniam RM.
    AJR Am J Roentgenol; 2016 Apr 15; 206(4):846-55. PubMed ID: 27003053
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH, Chiu NT, Su WC, Guo HR, Lee BF.
    Radiology; 2012 Aug 15; 264(2):559-66. PubMed ID: 22692034
    [Abstract] [Full Text] [Related]

  • 13. Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis.
    Son SH, Lee SW, Jeong SY, Song BI, Chae YS, Ahn BC, Lee J.
    AJR Am J Roentgenol; 2015 Oct 15; 205(4):878-85. PubMed ID: 26204115
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters.
    Chang S, Kim SJ.
    Cancer Biother Radiopharm; 2016 Feb 15; 31(1):1-6. PubMed ID: 26844846
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
    Chung HH, Kang SY, Ha S, Kim JW, Park NH, Song YS, Cheon GJ.
    J Gynecol Oncol; 2016 Mar 15; 27(2):e15. PubMed ID: 26768781
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of FDG-PET and DWI in breast cancer.
    Kitajima K, Miyoshi Y, Yamano T, Odawara S, Higuchi T, Yamakado K.
    Ann Nucl Med; 2018 Jan 15; 32(1):44-53. PubMed ID: 29134565
    [Abstract] [Full Text] [Related]

  • 19. Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy.
    Groheux D, Hatt M, Hindié E, Giacchetti S, de Cremoux P, Lehmann-Che J, Martineau A, Marty M, Cuvier C, Cheze-Le Rest C, de Roquancourt A, Visvikis D, Espié M.
    Cancer; 2013 Jun 01; 119(11):1960-8. PubMed ID: 23504954
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer.
    Chung HH, Lee I, Kim HS, Kim JW, Park NH, Song YS, Cheon GJ.
    Gynecol Oncol; 2013 Sep 01; 130(3):446-51. PubMed ID: 23791826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.